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Down syndrome (DS) is an aneuploidy syndrome that is caused by trisomy for human
chromosome 21 resulting in a characteristic cognitive and behavioral phenotype,
which includes executive functioning and adaptive behavior difficulties possibly due to
prefrontal cortex (PFC) deficits. DS also present a high risk for early onset of Alzheimer
Disease-like dementia. The dopamine (DA) system plays a neuromodulatory role in the
activity of the PFC. Several studies have implicated trait differences in DA signaling on
executive functioning based on genetic polymorphisms in the genes encoding for the
catechol-O-methyltransferase (COMTVal158Met) and the dopamine transporter (VNTR-
DAT1). Since it is known that the phenotypic consequences of genetic variants are
modulated by the genetic background in which they occur, we here explore whether
these polymorphisms variants interact with the trisomic genetic background to influence
gene expression, and how this in turn mediates DS phenotype variability regarding PFC
cognition. We genotyped 69 young adults of both genders with DS, and found that
VNTR-DAT1 was in Hardy-Weinberg equilibrium but COMTVal158Met had a reduced
frequency of Met allele homozygotes. In our population, genotypes conferring higher DA
availability, such as Met allele carriers and VNTR-DAT1 10-repeat allele homozygotes,
resulted in improved performance in executive function tasks that require mental
flexibility. Met allele carriers showed worse adaptive social skills and self-direction, and
increased scores in the social subscale of the Dementia Questionnaire for People with
Intellectual Disabilities than Val allele homozygotes. The VNTR-DAT1 was not involved in
adaptive behavior or early dementia symptoms. Our results suggest that genetic variants
of COMTVal158Met and VNTR-DAT1 may contribute to PFC-dependent cognition,
while only COMTVal158Met is involved in behavioral phenotypes of DS, similar to euploid
population.
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INTRODUCTION
Down syndrome (DS) is an aneuploidy syndrome that is
most commonly caused by trisomy for human chromosome
21 (HSA21) leading to a cognitive and behavioral phenotype
characterized by psychomotor delay, cognitive and behavioral
deficits, and high risk for early onset of Alzheimer Disease
(AD)-like dementia (Grieco et al., 2015). Executive function
and adaptive behavior are impaired in DS adults, with the
majority of studies showing specific deficits in working memory,
attention, mental flexibility, and inhibitory control (Edgin
et al., 2012). These functions are commonly ascribed to
the prefrontal cortex (PFC) and frontostriatal networks. The
function of these circuits relies heavily on neuromodulation,
in particular on dopamine (DA) (Miller and Cohen, 2001)
These findings are consistent with structural imaging evidences
showing reductions in gray matter volumes in the frontal
cortex and cingulate gyrus of DS adults (Rowe et al., 2006).
While it is assumed that many of this phenotypic DS
features stem from enhanced expression of a set of genes
harbored within the HSA21, (Korenberg et al., 1994) there
is few information about how genetic variants out of the
chromosome 21 would be affected by the aneuploidy genomic
context.
In the general population, polymorphisms known to influence
DA levels in the PFC, such as VNTR in the gene of the
DA transporter (DAT) and Val158Met in the gene of the
catechol-O-methyltransferase (COMT), are associated to PFC
executive function (Caldú et al., 2007; Witte and Flöel, 2012).
The COMTVal158Met polymorphism (rs4680) is a SNP (single
nucleotide polymorphism) that causes the substitution of a Valine
for a Methionine at position 158/108 (Lachman et al., 1996) and
has been shown to affect COMT expression, which is reduced
in the Met allelic variant carriers. The DAT1 polymorphism
is a VNTR (variable number tandem repeat) of 40 nucleotides
that can range from three to eleven repetitions and has been
shown to affect expression of DAT, with the 10-repeat allele being
associated with lower DAT levels than the 9-repeat allele (van de
Giessen et al., 2009; Shumay et al., 2011). Both the Met allelic
variant and 10-repeat allele would result in greater availability of
DA in the PFC, which may be linked to better PFC-dependent
cognitive skills (Meyer-Lindenberg et al., 2005; Wonodi et al.,
2009; Barnett et al., 2011), whereas these same alleles had been
associated with a disadvantage in adaptive behavior (Mier et al.,
2009; Koutsilieri et al., 2014).
In DS human brains, the response to dopaminergic
stimulation is depressed in post-mortem cerebral cortex
(Lumbreras et al., 2006), and reductions in dopamine and its
acidic metabolites (DOPAC and HVA) have been detected in
DS fetal and adult brains (Risser et al., 1997; Schneider et al.,
1997; Whittle et al., 2007). However, only two studies have
explored DA genetic polymorphisms. A family-based analysis
revealed significant over-transmission of a DRD4 VNTR allele,
which encodes for D4 dopamine receptor for DS (Das Bhowmik
et al., 2008). In a second study, the 7-repeat allele of the DRD4
polymorphism was associated to behavioral and executive
functions difficulties in children with DS (Mason et al., 2015).
Since it is known that the phenotypic consequences of genetic
variants are modulated by the genetic background in which they
occur, we here explored whether COMTVal158Met and VNTR-
DAT1 variants interact with the trisomic genetic background to
influence gene expression, and how this in turn mediates DS
phenotypes. We hypothesized that COMTVal158Met and VNTR-
DAT1 polymorphisms may influence cognitive and behavioral
skills differentially to euploid population.
MATERIALS AND METHODS
Subjects
For this cross-sectional study 87 young adults of both genders
with DS were drawn from the baseline exploration of a
clinical trial carried out by our research group (TESDAD
Study ClinicalTrials.gov Identifier: NCT01699711). Participants
were excluded if they had neurological disorders other than
DS, relevant medical diseases, co-morbid mental disorders
or were under any pharmacological treatment that could
interfere with cognitive function. Exclusion criteria also included
severe language deficit (significant speech and/or comprehension
limitations), behavioral disturbances and/or poor level of
collaboration during the assessment. Four subjects were excluded
for speech and language comprehension limitations, and two
declined to participate. Subject disposition, withdrawals and the
composition of the primary analysis population are shown in the
CONSORT diagram (Supplementary Figure 1).
In the present study, the genotype analysis was performed
in the whole eligible sample (n = 81), 10 subjects could not be
genotyped because an insufficient amount of DNA and 11–repeat
allele carriers were excluded of the DAT polymorphism analysis
since we only detected two subjects, resulting in a final sample
of 69 participants of both genders (M = 35, F = 34) with any
of the DS genetic variations (trisomy 21; n = 65, partial trisomy;
n= 2, mosaic; n= 1 or translocation; n= 1), mean age of 25 years
(range = 18–37, SD = 4.4) and mean IQ of 45 (range = 40–86,
SD= 8.7).
The data of a sample of healthy control Spanish subjects
genotyped for COMTVal158Met [n = 93, mean age = 22.8
(4.1), sex = 49 M, 44 F; (Cuyàs et al., 2011)], and VNTR-DAT1
[n = 57, mean age = 22.7 (2.83), sex = 57 M, 0 F; unpublished
data] were drawn from a previous study (CEIC-IMAS 99/935/I
2001/1226/I), and were used to assess whether the genotype
frequency in the TESDAD DS population was in equilibrium.
Genotype Analysis
Genomic DNA was extracted from the peripheral blood
leukocytes of all the participants using Flexi Gene DNA kit
(Qiagen Iberia, S.L., Spain) according to the manufacturer
instructions. COMTVal158Met allelic variants were determined
as previously described (Verdejo-García et al., 2013). VNTR
polymorphism of VNTR-DAT1 was evaluated by PCR using
the following primers 5′TGTGGTGTAGGGAACGGCCTGAG-
3′ (forward) and 5′CTTCCTGGAGGTCACGGCTCAAGG-3′
(reverse), the reaction conditions for this experiment were
the following: 1X PCR Amplification buffer and 1X PCR
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Enhancer solution (Invitrogen, Carlsbad, CA), 1.5 mM MgSO4,
0.2 mM dNTPs, 0.2 µmol of each primer, 1.75 U of Taq DNA
polymerase (Invitrogen), and approximately 50 ng of genomic
DNA as template. The reaction was carried out on the following
conditions: an initial denaturation of 5 min. at 95◦C, followed by
50 cycles as follows: 30 s denaturation at 95◦C, 30 s annealing
at 63◦C, and 45 s elongation at 68◦C, and a final elongation
step at 72◦for 5 min. The PCR products were separated by
electrophoresis on a 2% agarose gel, being the 9-allele 440 bp, and
the 10-allele 480 bp.
Neuropsychological Testing
We focused on PFC-dependent cognition, exploring components
of executive functioning, specifically the following domains:
impulsivity, attention, working memory, mental flexibility,
planning ability, inhibitory control and adaptive behavior.
A detailed description of the tests is provided in Supplementary
Annex 1.
Intellectual quotient (IQ) was estimated using the Kaufman
Brief Intelligence Test (K-BIT). Impulsivity was measured
analyzing the relation between response times and errors in a set
of tests from the non-verbal Cambridge Neuropsychological Test
Automated Battery (CANTAB): Motor screening test (MOT),
Simple Reaction Time (SRT), and Spatial Span Forward Recall
(SSP-FR). To assess the attentional span the Digits Span Forward
Recall (DSP-FR) from WAIS-III and the Spatial Span Forward
(CANTAB) were administered. Working memory for visual and
verbal information was evaluated with the Spatial Span Backward
Recall (SSP-BR, CANTAB) and the Digits Span Backward
Recall (DSP-BR) from WAIS-III, respectively. Mental flexibility
was measured rating switching ability and reversal learning.
Switching ability (times subject change from one semantic
category to a new one) was assessed with the Semantic Fluency
Word Generation Task (SFWGT, animals in 1 min), and reversal
learning (disengagement from inappropriate strategies when
reinforcement contingencies change), with the Weigl Color-
Form Sort Test (WCFST). Planning ability was measured using
the Tower of London from Drexel University (ToLDx) and the
Cats & Dogs test was used to assess inhibitory control. To assess
adaptive behavior, the adult version of the Adaptive Behavior
Assessment System-Second Edition (ABAS-II) was used.
Finally, since early Alzheimer’s disease like dementia in DS
population courses with a progressive decline of the DA system
and a faster degeneration of the PFC, affecting executive function
(Fernandez and Reeves, 2015), we explored early dementia
symptoms with the Dementia Questionnaire for People with
Intellectual Disabilities (DMR).
Statistical Analysis
Descriptive analyses were carried out for sociodemographic
and clinical parameters of all the participants and for all
neuropsychological variables, providing measures of mean and
standard deviation.
The genotypic frequency of the different polymorphisms
was tested by Hardy-Weinberg equilibrium. To study the
association between polymorphisms and cognition, two-way
ANOVA models were fitted for each of the cognitive tests and
questionnaires scores. The 2 genes were included in the models
as independent factors and treated as binary variables, Val allele
homozygotes vs. Met allele carriers (COMTVal158Met) and 10-
repeat allele homozygotes vs. 9-repeat allele carriers (VNTR-
DAT1), respectively. In addition, possible sources of epistatic
effects on cognition were considered by assessing the interaction
between COMTVal158Met and VNTR-DAT1 genotypes in each
of the two-way ANOVA models.
The statistically significant associations were fixed at a
significance level of 0.05, using the model-based estimated mean
differences as the effect size of interest. All statistical analyses were
performed using the statistical software packages SPSS (Version
18.0; SPSS Inc., Chicago, IL, USA) and R (Version 3.1.1; The R
Foundation for Statistical Computing, Vienna, Austria).
RESULTS
Distribution of Polymorphisms
Socio-demographic data and cognitive parameters for all the
neuropsychological variables of the 69 participants are provided
in the Supplementary Table 1.
In our study, the euploid Spanish population was used
to obtain the expected frequencies for the Hardy-Weinberg
equilibrium (Table 1). The proportion of COMTVal158Met allelic
frequencies among the Spanish reference population (n = 93)
was similar to the reference CEU (Utah residents with Northern
and Western European ancestry), and TSI (Tuscans from Italy)
HapMap populations (HapMap, n.d.); (Table 1). No data from
CEU and TSI HapMap reference populations was available for
the proportion of VNTR-DAT1 allelic frequencies.
In the TESDAD DS population, we found a Hardy–Weinberg
disequilibrium (χ2 = 6.47, p < 0.039) due to an under-
representation of the Met/Met genotype in the COMTVal158Met
polymorphism, as compared to the CEU, TSI ,and Spanish
populations. Conversely, VNTR-DAT1 allele frequency was in the
expected Hardy–Weinberg equilibrium compared to the Spanish
population (n= 57); (Table 1).
VNTR-DAT1 and COMTVal158Met Effects
on Cognitive and Functional
Performance
Table 2; Figures 1 and 2 show the main effects in components
of executive functioning and caregiver’s rating scores between
VNTR-DAT1 and COMTVal158Met genotypes. The VNTR-
DAT1 10-repeat allele homozygotes showed statistically
significant shorter response times in the CANTAB Simple
Reaction Time and Spatial Span Forward Recall tasks, not
linked to impulsivity since they were not accompanied by a
higher number of errors. 10-repeat allele homozygotes also
showed statistically significant better performance of tasks
requiring mental flexibility, as measured by the SFWGT, but
not by the WCFST. Taken together, these data indicate that in
our DS population the 10-repeat allele homozygotes are faster
responders in attentional and psychomotor tasks and have better
mental flexibility. No statistically significant association was
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TABLE 1 | Distribution of COMTVal158Met and VNTR-DAT1 allele frequencies in the DS and reference populations.
Hap map CEU population Hap map TSI population Spanish population TESDAD DS population (Spanish)
COMTVal158Met
Met/Met (A/A) 28 (0.248) 20 (0.196) 21 (0.225) 6 (0.087)
Val/Met (G/A) 52 (0.460) 52 (0.510) 45 (0.484) 38 (0.550)
Val/Val (G/G) 33 (0.292) 30 (0.294) 27 (0.290) 25 (0.362)
VNTR-DAT1 10/10 30 (0.526) 35 (0.507)
10/9 23 (0.403) 26 (0.377)
9/9 4 (0.070) 8 (0.116)
CEU, Utah residents with Northern and Western European ancestry; the TSI, Tuscans from Italy; DS, Down syndrome. Data represent the number of individuals bearing
each genotype, and parenthesis account for genotypic frequencies (0–1).
TABLE 2 | VNTR-DAT1 and COMTVal158Met effects on cognitive and functional variables in the TESDAD DS population.
Test Function assessed Polymorphism Figure Estimate Standard error t-value p-value
SSP-FR (CANTAB) Mean time to response VNTR-DAT Figure 1A 537 270 1.999 0.05
SRT (CANTAB) Mean time to respond VNTR-DAT Figure 1B 117 48 2.424 0.018
MOT(CANTAB) Mean time to respond VNTR-DAT 137 77 1.772 0.081
SFWGT Switching ability: MF VNTR-DAT Figure 1C –1.5 0.5 –3.265 0.002
WCFST Reversal learning: MF VNTR-DAT –0.8 0.4 –1.921 0.059
SFWGT Switching ability: MF COMTVal158Met Figure 2A –1.4 0.5 –2.935 0.005
ABAS-Social Skills Adaptive social behavior COMTVal158Met Figure 2B 6.99 2.9 2.453 0.017
ABAS-Self-Direction Capacity of regulate behavior to COMTVal158Met Figure 2C 7.65 3.7 2.08 0.041
the demands of a situation.
DMR-SOS Social symptoms of dementia COMTVal158Met Figure 2D –2.1 1 –2.108 0.039
SSP, Spatial Span; FR, Forward Recall; SRT, Simple Reaction Time; MOT, Motor Screening; SFWGT, Semantic Fluency Word Generation Task; WCFST, Weigl Color-Form
Sort Test; CANTAB, Cambridge Neuropsychological Test Automated Battery; DMR-SOS, Dementia Questionnaire for Persons with Intellectual Disabilities (Sum of Social
Scores); ABAS, Adaptive Behavior Assessment System; MF, mental flexibility; Estimate, estimated mean difference; Standard Error, standard error of the estimated mean
difference; t-value, Value of the t-statistics; F, Figure; G, Graphic. Two-way ANOVA model was carried out to analyse main differences between allelic groups of each
polymorphism regarding cognitive and functional outcomes.
Statistically significant associations above a significance level of 0.05 are represented as bold values.
found between the VNTR-DAT1 polymorphism and parental
reports (ABAS-II and DMR).
Regarding COMTVal158Met, Met allele carriers showed no
differences in response time in the CANTAB tasks but we
detected the same profile as for 10-repeat allele homozygotes
regarding mental flexibility that was better as assessed by
the SFWGT, but not WCFST. In addition, Met allele carriers
had statistically significant worse parental reports referred to
adaptive behavior, specifically in the social skills and self-
direction subscales of ABAS-II, and statistically significant higher
early dementia rates in the DMR social scale (DMR-SOS) than
Val allele homozygotes. Thus, in our population, the Met allele
carriers have a greater mental flexibility but worse adaptive
behavior, along with higher social deterioration.
No statistically significant differences were found between
VNTR-DAT1 or COMTVal158Met genotypes with regards to
attentional span (The Digits Span Forward Recall, The Spatial
Span Forward Recall from CANTAB), working memory (the
Digits Span Backward Recall from WAIS and the Spatial Span
Backward Recall from CANTAB), planning ability (the Tower of
London from Drexel University, ToLDx), or inhibitory control
(the Cats & Dogs test).
Interactions between genotypes were considered for each
cognitive and functional variable; however, no statistically
significant genotype interaction between VNTR-DAT1 and
COMTVal158Met polymorphisms was detected.
DISCUSSION
Since it is known that the phenotypic consequences of genetic
variants are modulated by the genetic background in which they
occur, we here examined the association between DA related
polymorphisms VNTR-DAT1 and COMTVal158Met and inter-
individual differences in executive function, adaptive behavior
and early symptoms of dementia in DS young adults. We
show that genotypes conferring higher DA synaptic availability
(Met allele carriers and 10-repeat allele homozygotes), result in
improved performance in executive function tasks that require
mental flexibility. We also observe worse social skills and self-
direction and earlier social symptoms of dementia in Met allele
carriers but not in 10-repeat allele homozygotes.
In our DS population the genotype distribution for
VNTR-DAT1 was in Hardy-Weinberg equilibrium, but
the COMTVal158Met had a reduced frequency for Met
allele homozygotes. Even though, there is a need of a more
extensive analysis of the frequencies of the COMTVal158Met
polymorphism in the DS population, and a triplet analysis
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FIGURE 1 | Cognitive performance associated with VNTR-DAT1 polymorphisms. Box plots represent the cognitive performance of allelic groups of
VNTR-DAT1 polymorphism. 10-repeat homozygotes (gray boxes) displayed shorter response times in CANTAB (A) SSP (p < 0.05; two way ANOVA) and (B) SRT
tasks (p < 0.016; two way ANOVA), and better mental flexibility measured by (C) SFWGT (Switching strategy; p < 0.016; two way ANOVA) than 9-repeat carriers
(white boxes). The boxplots show the median and interquartile range. Dots indicate individual values.
would be required to confirm this observation, the reduced Met
frequency in our population could be explained as a case of
natural selection against the Met allele homozygotes since in
the general population it has been observed that women who
are carriers of the Met allele have a higher risk of miscarriage
(Khadzhieva et al., 2014).
We here hypothesized that DA related polymorphisms would
impact executive function in DS, but not necessarily in the
same way as in euploid population, since the genetic trisomic
background and the underlying cognitive deficits may influence
the variants’ effects. Main differences in cognitive performance
between DS and age-matched controls have already been
reported in our previous works (de Sola et al., 2015; Hoyo et al.,
2015). Specifically, we detected a substantial deficit on executive
functions, being the most impaired: semantic verbal fluency
(SFWGT: total word production) and mental flexibility (SFWGT:
switching ability). In our DS group, the switching ability, which
allow subjects to change from one semantic category to another,
is associated (p < 0.001, r = 0.689) to a higher word production
leading to a better performance of the task.
We here found that 10-repeat allele homozygotes were faster
respondents in attentional tasks (SRT and SSP-FR), and this same
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FIGURE 2 | Cognitive and functional performance associated to COMTVal158Met polymorphisms. Box plots represent the behavioral and cognitive
performance of allelic groups of COMTVal158Met polymorphism. Met carriers (gray boxes) performed better in mental flexibility measured by (A) SFWGT (Switching
strategy; p < 0.005; two way ANOVA) and had worse parental reports in two ABAS-II subscales: (B) ABAS-Self-Direction (p < 0.041; two way ANOVA) and
(C) ABAS-Social Skills (p < 0.017; two way ANOVA), and also in the (D) social scale of the DMR; DMR-SOS (p < 0.039; two way ANOVA) than Val homozygotes
(white boxes). The boxplots show the median as well as the interquartile range. Dots indicate individual values.
genotype and Met allele carriers were associated to better mental
flexibility showing better switching abilities (SFWGT).
Previous studies reported that healthy subjects carrying
the 10-repeat allele were more impulsive than 9-repeat
allele carriers, being faster but committing more errors
in a non-verbal attentional task (CPT, CANTAB; Caldú
et al., 2007). Here, the faster responses of 10-repeat allele
homozygotes as compared to the 9-repeat carriers could
not be considered as a sign of impulsivity as there was no
association between faster responses and the errors made.
An association between 10-repeat allele and ADHD (Cornish
et al., 2005), in which impulsivity is a core characteristic
(Winstanley et al., 2006), has also been demonstrated, being
the hyperactive/impulsive-ADHD-type linked with the 10-
repeat allele (Waldman et al., 1998). Although there is a high
ADHD prevalence in DS population (Ekstein et al., 2011),
in our study there was no ADHD comorbidity nor signs of
impulsivity at a group level, so we could not determine such
association.
The association between Met allele carriers and better mental
flexibility is in agreement with previous studies in general
population in which subjects with the low-activity Met allele were
associated to fewer perseverative errors in a mental flexibility task
(Malhotra et al., 2002).
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Taken together, our results indicate that 10-repeat allele
homozygotes and Met allele carriers in our DS population have
better mental flexibility. Interestingly, a reduction of the levels of
DA in the frontal cortex of fetal DS brains has been observed
(Whittle et al., 2007) that is associated with dysfunctional
neuronal development in DS. Therefore, even though we have
not directly measured PFC DA availability, Met allele carriers and
10-repeat allele homozygotes, which are supposed to have higher
frontal DA availability, could be compensating PFC dependent
executive functions (Rowe et al., 2006).
Since executive skills are strongly associated with adaptive
behavior (ABAS-II), we explored how these polymorphisms were
linked to adaptive behavior skills. Our results showed differences
in parental-reports between COMTVal158Met genotypes but
not between VNTR-DAT1 genotypes. Met allele carriers showed
worse adaptive behavior, concretely worse social skills and self-
direction. Self-direction is a subscale of the ABAS-II which
measures the executive control in daily living. Social abilities are
also mediated by executive function, which helps the subject to
adapt to different social situations regulating emotion (Campbell
et al., 2015). Previous studies in general population have also
find a positive association between the Val allele and social skills
(Walter et al., 2011). Our results showed that the Met allele
is conferring an advantage in cognition (mental flexibility) but
penalizing for adaptive behavior skills, which has been shown
either in healthy and disease conditions (Mier et al., 2009).
Finally, Met allele carriers were also associated to worse
scores in the social scale of the DMR (DMR-SOS) than
high-activity Val allele homozygotes. Conversely, some reports
suggest that increased synaptic DA catabolism promotes the
neurodegeneration within DA-innervated brain regions and thus,
progressive cognitive and behavioral decline associated with
AD (Gennatas et al., 2012). However, even though the Met
allele (increasing DA availability) may confer resistance to AD
(Gennatas et al., 2012), in our sample Met allele carriers did
not show differences in the general DMR score. Thus, we
interpret this result as an association between Met allele and
social deterioration (DMR-SOS), instead of a link with early social
dementia symptoms, since Met allele carriers also showed worse
adaptive social behavior (ABAS-II).
In DS, one study has reported that the DRD4 7-repeat allele
was related to behavioral and executive functions difficulties
(Mason et al., 2015). We here did not explore these variants
and thus, possible interactions of our polymorphisms and the
DRD4 gene variants could also be contributing to the detected
phenotypes. Other genotypes examined seem to little contribute
(genetic polymorphisms in the dopaminergic and serotonergic
system the DRD4 exon 3 VNTR and the 5-HTTLPR) to the
cognitive dysfunctions observed in DS (Das Bhowmik et al.,
2008).
Limitations
First, even though the sample size of this study is larger than
other single-gene association studies in people with DS (Mason
et al., 2015), a larger sample size would have been ideal to
confirm our results. However, limited sample sizes are expected
in most studies conducted in special populations. Secondly, we
did not have a comparison group, although our effects were
similar to typically developing samples reported in the literature.
Future studies should explore whether COMTVal158Met and
VNTR-DAT1 effects on executive function and behavior in
adults with DS are additive or enhanced relative to effects in
typically developing individuals. Finally, the large number of
statistical tests carried out may increase the probability of Type-
1 errors. Nonetheless, since this is rather an exploratory than
a confirmatory study, no correction to control a family-wise
significance level of 0.05 has been applied in order not to increase
the probability of Type-2.
CONCLUSION
Our study has evaluated whether allelic variants of specific non-
trisomy 21 genes (COMTVal158Met and VNTR-DAT1) could
contribute to explain cognitive and behavioral variability in
DS phenotype. While the phenotype is most likely due to a
subtle increase in gene dosage, how genetic variants out of the
chromosome 21 and related to DA transmission would affect
variability in prefrontal cognition in an aneuploidy genomic
context is little explored. Since it is known that the phenotypic
consequences of genetic variants are modulated by the genetic
background in which they occur, we here explore whether
COMTVal158Met and VNTR-DAT1 variants interact with the
trisomic genetic background to influence gene expression, and
how this in turn mediates Down syndrome phenotypes. Our
results suggest that genotypes conferring higher DA availability
as for Met allele carriers and 10-repeat allele homozygotes
result in improved mental flexibility. With respect to parental
reports, worse rates in adaptive behavior regarding social skills
and self-direction were found only in the Met allele carriers,
along with higher social deterioration. We conclude that genetic
variations related to DA transmission may have an impact on
the cognitive and behavioral DS phenotype similar to the general
population. Nevertheless, further longitudinal studies are needed
to confirm our results and determine whether these differences
are unaffected or significantly enhanced by Trisomy 21 on
molecular (epigenetic) and cognitive/behavioral and functional
levels.
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